In addition, the authors demonstrated that the treatment of these cells with DNMT inhibitors (1 μM decitabine) has been shown to recover TLR2 expression in oral mucosal cells and also appear to be important in inducing an inflammatory response during infection [29]. This evidence concerns the gene DNMT1 and infection.